Skip to content

The HORIZON-IC study: The effect of Intensive Care Unit-specific Virtual Reality (ICU-VR) on mental health and health-related quality of life in critical illness survivors.

The HORIZON-IC study: The effect of Intensive Care Unit-specific Virtual Reality (ICU-VR) on mental health and health-related quality of life in critical illness survivors. - The HORIZON-IC study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON54059
Enrollment
270
Registered
2021-10-20
Start date
2021-12-14
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-intensive care syndroom (angst/post-traumatische stress/depressie) anxiety depression post-traumatic stress disoder

Interventions

An Intensive Care Unit-specific Virtual Reality (ICU-VR) intervention, designed by an interdisciplinary team of intensivists, ICU nurses, a psychiatrist, a psychologist, and a former ICU patient, to

Sponsors

Franciscus Gasthuis & Vlietland
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • >=18 years old • ICU-Length of stay >=72 hours • Mechanical ventilation >=24 hours • Able to read and speak in the Dutch language • Signed informed-consent

Exclusion criteria

Exclusion criteria: • Documented active, established psychiatric disease (for instance personality disorders, posttraumatic stress disorder, schizophrenia, severe depression). Patients who have suffered from psychiatric diseases in the past can participate. • A history or a primary neurological impairment necessitating ICU treatment (patients admitted with traumatic brain injury, CVA, stroke, meningitis). • Decreased cognitive functioning during inclusion, as defined by a Telephone Interview for Cognitive Status (TICS) score less than 27. • Active delirium during inclusion • Lack of formal home address • Moribund patients at the ICU or hospital ward with a life expectancy

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the difference in the severity of PTSD-related symptoms six months after ICU discharge between patients in the control group, patients in the early ICU-VR group, and patients in the late ICU-VR group.

Secondary

MeasureTime frame
The secondart study endpoints are the severity of PTSD-, anxiety, and depression-related symptoms and the prevlaence of probable PTSD, anxiety and depression up to 12 months after hospital discharge and the overall, mental, and physical health-related quality of life up to 12 months after hospital discharge.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)